Literature DB >> 35015309

Regulatory T cells: A review of manufacturing and clinical utility.

Tewodros Mamo1, Keli L Hippen2,3, Margaret L MacMillan2,3, Claudio G Brunstein2,4, Jeffrey S Miller2,4, John E Wagner2,3, Bruce R Blazar2,3, David H McKenna1.   

Abstract

Entities:  

Mesh：

Year:  2022        PMID： 35015309      PMCID： PMC8986575          DOI： 10.1111/trf.16797

Source DB:  PubMed          Journal:  Transfusion        ISSN： 0041-1132            Impact factor:   3.337


× No keyword cloud information.
  44 in total

1.  Prevention of Allograft Rejection by Use of Regulatory T Cells With an MHC-Specific Chimeric Antigen Receptor.

Authors:  F Noyan; K Zimmermann; M Hardtke-Wolenski; A Knoefel; E Schulde; R Geffers; M Hust; J Huehn; M Galla; M Morgan; A Jokuszies; M P Manns; E Jaeckel
Journal:  Am J Transplant       Date:  2017-02-06       Impact factor: 8.086

Review 2.  Antigen-specific regulatory T cells: are police CARs the answer?

Authors:  Nicholas A J Dawson; Megan K Levings
Journal:  Transl Res       Date:  2017-06-19       Impact factor: 7.012

Review 3.  Immune regulatory cell infusion for graft-versus-host disease prevention and therapy.

Authors:  Bruce R Blazar; Kelli P A MacDonald; Geoffrey R Hill
Journal:  Blood       Date:  2018-05-04       Impact factor: 22.113

4.  Alloantigen-specific regulatory T cells generated with a chimeric antigen receptor.

Authors:  Katherine G MacDonald; Romy E Hoeppli; Qing Huang; Jana Gillies; Dan S Luciani; Paul C Orban; Raewyn Broady; Megan K Levings
Journal:  J Clin Invest       Date:  2016-03-21       Impact factor: 14.808

5.  Type 1 diabetes immunotherapy using polyclonal regulatory T cells.

Authors:  Jeffrey A Bluestone; Jane H Buckner; Mark Fitch; Stephen E Gitelman; Shipra Gupta; Marc K Hellerstein; Kevan C Herold; Angela Lares; Michael R Lee; Kelvin Li; Weihong Liu; S Alice Long; Lisa M Masiello; Vinh Nguyen; Amy L Putnam; Mary Rieck; Peter H Sayre; Qizhi Tang
Journal:  Sci Transl Med       Date:  2015-11-25       Impact factor: 17.956

6.  Polyclonal Regulatory T Cell Therapy for Control of Inflammation in Kidney Transplants.

Authors:  S Chandran; Q Tang; M Sarwal; Z G Laszik; A L Putnam; K Lee; J Leung; V Nguyen; T Sigdel; E C Tavares; J Y C Yang; M Hellerstein; M Fitch; J A Bluestone; F Vincenti
Journal:  Am J Transplant       Date:  2017-08-14       Impact factor: 8.086

7.  Cryopreservation timing is a critical process parameter in a thymic regulatory T-cell therapy manufacturing protocol.

Authors:  Katherine N MacDonald; Sabine Ivison; Keli L Hippen; Romy E Hoeppli; Michael Hall; Grace Zheng; I Esme Dijke; Mohammed Al Aklabi; Darren H Freed; Ivan Rebeyka; Sanjiv Gandhi; Lori J West; James M Piret; Bruce R Blazar; Megan K Levings
Journal:  Cytotherapy       Date:  2019-12-03       Impact factor: 5.414

8.  Expression of a Chimeric Antigen Receptor Specific for Donor HLA Class I Enhances the Potency of Human Regulatory T Cells in Preventing Human Skin Transplant Rejection.

Authors:  D A Boardman; C Philippeos; G O Fruhwirth; M A A Ibrahim; R F Hannen; D Cooper; F M Marelli-Berg; F M Watt; R I Lechler; J Maher; L A Smyth; G Lombardi
Journal:  Am J Transplant       Date:  2017-02-01       Impact factor: 8.086

9.  Administration of CD4+CD25highCD127- regulatory T cells preserves β-cell function in type 1 diabetes in children.

Authors:  Natalia Marek-Trzonkowska; Malgorzata Mysliwiec; Anita Dobyszuk; Marcelina Grabowska; Ilona Techmanska; Jolanta Juscinska; Magdalena A Wujtewicz; Piotr Witkowski; Wojciech Mlynarski; Anna Balcerska; Jolanta Mysliwska; Piotr Trzonkowski
Journal:  Diabetes Care       Date:  2012-06-20       Impact factor: 19.112

10.  Factors affecting long-term efficacy of T regulatory cell-based therapy in type 1 diabetes.

Authors:  Natalia Marek-Trzonkowska; Małgorzata Myśliwiec; Dorota Iwaszkiewicz-Grześ; Mateusz Gliwiński; Ilona Derkowska; Magdalena Żalińska; Maciej Zieliński; Marcelina Grabowska; Hanna Zielińska; Karolina Piekarska; Anna Jaźwińska-Curyłło; Radosław Owczuk; Agnieszka Szadkowska; Krystyna Wyka; Piotr Witkowski; Wojciech Młynarski; Przemysława Jarosz-Chobot; Artur Bossowski; Janusz Siebert; Piotr Trzonkowski
Journal:  J Transl Med       Date:  2016-12-01       Impact factor: 5.531
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.